TIDMIUG
Intelligent Ultrasound Group PLC
02 September 2022
REACH
Intelligent Ultrasound Group plc
("IUG" or the "Company")
Launch of NeedleTrainer 2
Intelligent Ultrasound Group plc (AIM: IUG), the 'classroom to
clinic' ultrasound company, specialising in artificial intelligence
(AI) software and simulation, announces it has launched an updated
version of its 'first in kind' technology NeedleTrainer (TM),
making ultrasound-guided needle training even more accessible to
medical professionals, through a high performance, pocket-sized
wireless ultrasound machine - GE Healthcare's Vscan(TM) Air.
NeedleTrainer is a real-time simulation tool, which has been
designed to develop the needle-probe co-ordination skills required
for safe ultrasound guided interventional procedures.
The first of its kind, NeedleTrainer uses a retractable needle,
with the ability to add virtual image overlays to simulate needling
non-invasively on a live participant, using a live ultrasound scan.
This enables trainees to develop hand-eye coordination, optimum
positioning, and accuracy in ultrasound-guided interventional
procedures in a simulated clinical environment without delaying
patient care or risking patient safety.
Ten months since the original version launched in the
marketplace, and the platform is already being embraced by regional
anesthesia medical education schools including Health Education and
Improvement Wales and University College London Hospital to expand
training opportunities and drive curriculum changes.
In line with IUG's vision to 'unlock ultrasound for everyone',
the latest version of NeedleTrainer makes ultrasound-guided
needling even more accessible to medical professionals. Previously
only available to users with an existing compatible ultrasound
system, IUG has now expanded this offering. The latest generation
of NeedleTrainer incorporates a GE Vscan Air; a wireless, handheld
ultrasound probe that makes the system portable, removes the need
to re-purpose a console-based ultrasound machine for training,
while making the platform available to more institutions.
NeedleTrainer is available in two offerings: as a needle
training simulator, applicable to any speciality that performs
ultrasound guided needling. For regional anaesthesia there is also
NeedleTrainer Plus, which includes the needle training simulator,
with a built in trainer for peripheral nerve blocks (PNB) that
include AI powered overlay of body structures option for the ten
most common blocks when training on regional anaesthesia.
Once a practitioner is competent, they can then use the
standalone ScanNav Anatomy PNB device in the clinic for real-time
AI assistance of ultrasound-guided regional anesthesia.
Dr Dennis Cochlin, MB BCh FRCR, Consultant in General Ultrasound
at the University Hospital of Wales, Cardiff commented: "This is a
great example of how invasive procedures can be taught in a safe
environment. This is particularly important for the increasing
number of practitioners who use ultrasound to guide procedures, but
where ultrasound is not their main specialty. However, anyone who
practices ultrasound guided needling, however experienced, will
welcome this."
Nicholas Sleep, Chief Technology Officer of Intelligent
Ultrasound commented: "Still a 'first in kind' platform,
NeedleTrainer 2 is the latest development in IUG's vision to make
ultrasound simpler to use and easier to learn. We're pleased to
extend our partnership with GE Healthcare by incorporating the
Vscan Air into our system, which makes this technology portable and
available to any medical education programme which teaches
ultrasound-guided needling. Cent res will be able to adapt to new
curriculum requirements, without impacting clinical hours or
patient safety."
GE Healthcare has a century long track record of delivering high
impact healthcare innovations, with more than 30 years in
ultrasound. GE was the first to introduce a pocket-sized color
ultrasound to the market; the over 30,000 Vscan units in the
pockets of clinicians in 100 countries impacts the care of 50
million patients worldwide.
To learn more about NeedleTrainer, readers can visit the IUG
website .
Intelligent Ultrasound Group www. intelligentultrasound.com
plc
Stuart Gall, CEO Tel: +44 (0)29 2075 6534
Helen Jones, CFO
Walbrook PR Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com
Anna Dunphy Mob: +44 (0)7876 741 001
About Intelligent Ultrasound Group
Intelligent Ultrasound (AIM: IUG) is one of the world's leading
'classroom to clinic' ultrasound companies, specialising in
real-time hi-fidelity virtual reality simulation for the ultrasound
training market ('classroom') and artificial intelligence-based
clinical image analysis software tools for the diagnostic medical
ultrasound market ('clinic'). Based in Cardiff in the UK and
Atlanta in the US, the Group has two revenue streams:
Simulation
Real-time hi-fidelity ultrasound education and training through
simulation. Our main products are the ScanTrainer obstetrics and
gynaecology training simulator, the HeartWorks echocardiography
training simulator, the BodyWorks Eve Point of Care and Emergency
Medicine training simulator with Covid-19 module and the new
BabyWorks Neonate and Paediatric training simulator. To date over
1,400 simulators have been sold to c. 700 medical institutions
around the world.
Clinical AI software
Deep learning-based algorithms to make ultrasound machines
smarter and more accessible using our proprietary ScanNav
ultrasound image analysis technology. Current products on the
market utilising this technology are GE Healthcare's SonoLyst
software that is incorporated in their Voluson Expert 22 and SWIFT
ultrasound machines; ScanNav Anatomy PNB that simplifies
ultrasound-guided needling by providing the user with real-time
AI-based
anatomy highlighting for a range of medical procedures; and NeedleTrainer that teaches real-time ultrasound-guided needling and incorporates ScanNav Anatomy PNB.
www.intelligentultrasound.com
NOTE: ScanNav Anatomy PNB is CE approved, but not yet available
for sale in the US or any other territory requiring government
approval for this type of product.
About Reach announcements
This is a Reach announcement. Reach is an investor communication
service aimed at assisting listed and unlisted (including AIM
quoted) companies to distribute media only / non-regulatory news
releases into the public domain. Information required to be
notified under the AIM Rules for Companies, Market Abuse Regulation
or other regulation would be disseminated as an RNS regulatory
announcement and not on Reach.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRABLLFBLKLBBBV
(END) Dow Jones Newswires
September 02, 2022 06:09 ET (10:09 GMT)
Intelligent Ultrasound (LSE:MED)
Historical Stock Chart
From Oct 2024 to Nov 2024
Intelligent Ultrasound (LSE:MED)
Historical Stock Chart
From Nov 2023 to Nov 2024
